Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Non-interventional Retrospective Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer

NCT05769751 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT05769751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05769751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Non-interventional Retrospective Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer
Lead sponsor
Daiichi Sankyo
Phase
Observational
Overall status
Completed
Start date
March 15, 2023
Completion date
July 25, 2023
Enrollment
865 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer